{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:57:48Z","timestamp":1769093868503,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00272628"],"award-info":[{"award-number":["RS-2023-00272628"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118910","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:42:53Z","timestamp":1766079773000},"page":"118910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neutralizing endocan reduces blood pressure and improves endothelial function in angiotensin II-induced hypertensive mice"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0567-3031","authenticated-orcid":false,"given":"Eun Yi","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonhee","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Kyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118910_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","article-title":"Hypertension and cardiovascular risk: general aspects","volume":"129","author":"Kjeldsen","year":"2018","journal-title":"Pharm. Res"},{"issue":"9","key":"10.1016\/j.biopha.2025.118910_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","volume":"139","author":"Oparil","year":"2003","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.biopha.2025.118910_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.959285","article-title":"Hypertension as a risk factor for atherosclerosis: cardiovascular risk assessment","volume":"9","author":"Poznyak","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.biopha.2025.118910_bib4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/antiox13121454","article-title":"Oxidative stress in kidney injury and hypertension","volume":"13","author":"Arendshorst","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118910_bib5","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7","key":"10.1016\/j.biopha.2025.118910_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the renin-angiotensin system in vascular inflammation","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118910_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.endinu.2021.05.012","article-title":"Renin-angiotensin system: basic and clinical aspects-A general perspective","volume":"69","author":"Vargas","year":"2022","journal-title":"Endocrinol. Diabetes Nutr."},{"issue":"7","key":"10.1016\/j.biopha.2025.118910_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Griendling","year":"2021","journal-title":"Circ. Res"},{"issue":"39","key":"10.1016\/j.biopha.2025.118910_bib9","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.2174\/0109298673325682241114162014","article-title":"Oxidative stress biomarkers in hypertension","volume":"32","author":"Fountoulakis","year":"2025","journal-title":"Curr. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118910_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08037051.2014.972816","article-title":"Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan","volume":"24","author":"Celik","year":"2015","journal-title":"Blood Press"},{"issue":"3","key":"10.1016\/j.biopha.2025.118910_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","article-title":"Endothelial function: cardiac events","volume":"111","author":"Lerman","year":"2005","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.biopha.2025.118910_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3346\/jkms.2015.30.9.1213","article-title":"Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches","volume":"30","author":"Park","year":"2015","journal-title":"J. Korean Med Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118910_bib13","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/s41440-023-01402-y","article-title":"Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis","volume":"46","author":"Behnoush","year":"2023","journal-title":"Hypertens. Res"},{"key":"10.1016\/j.biopha.2025.118910_bib14","article-title":"Endocan: a key player of cardiovascular disease","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.biopha.2025.118910_bib15","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1038\/s41440-024-01885-3","article-title":"Current topic of vascular function in hypertension in 2023-2024","volume":"47","author":"Maruhashi","year":"2024","journal-title":"Hypertens. Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118910_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41440-023-01542-1","article-title":"How can endocan be used as a specific biomarker of endothelial dysfunction in hypertension?","volume":"47","author":"Hirooka","year":"2024","journal-title":"Hypertens. Res"},{"key":"10.1016\/j.biopha.2025.118910_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1438367","article-title":"Endocan, a novel glycoprotein with multiple biological activities, may play important roles in neurological diseases","volume":"16","author":"Liu","year":"2024","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118910_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","article-title":"Endocan: a novel inflammatory indicator in cardiovascular disease?","volume":"243","author":"Balta","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.biopha.2025.118910_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0253-7613.144891","article-title":"Endocan: a novel circulating proteoglycan","volume":"46","author":"Kali","year":"2014","journal-title":"Indian J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118910_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13050640","article-title":"The role of endocan in cardiometabolic disorders","volume":"13","author":"Klisic","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.biopha.2025.118910_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.24485","article-title":"Endocan elicits severe vascular inflammatory responses in vitro and in vivo","volume":"229","author":"Lee","year":"2014","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118910_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188672","article-title":"Proteoglycan endocan: a multifaceted therapeutic target in cancer","volume":"1877","author":"Pan","year":"2022","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"49","key":"10.1016\/j.biopha.2025.118910_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013407","article-title":"The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease A meta-analysis","volume":"97","author":"Zhao","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2025.118910_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.niox.2021.09.006","article-title":"Endocan alters nitric oxide production in endothelial cells by targeting AKT\/eNOS and NFkB\/iNOS signaling","volume":"117","author":"Kumar","year":"2021","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.biopha.2025.118910_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/metabo13050640","article-title":"The Role of Endocan in Cardiometabolic Disorders","volume":"13","author":"Klisic","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2025.118910_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1523-1755.2005.09911.x","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","volume":"68","author":"Remuzzi","year":"2005","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.biopha.2025.118910_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med"},{"issue":"47","key":"10.1016\/j.biopha.2025.118910_bib28","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","article-title":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney","volume":"103","author":"Crowley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2025.118910_bib29","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00335.2019","article-title":"Impact of angiotensin II-mediated stimulation of sodium transporters in the nephron assessed by computational modeling","volume":"317","author":"Edwards","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118910_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bph.15650","article-title":"Rodent models of hypertension","volume":"179","author":"Jama","year":"2022","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118910_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113588","article-title":"Effects of 3-methyladenine, an autophagy inhibitor, on the elevated blood pressure and arterial dysfunction of angiotensin II-induced hypertensive mice","volume":"154","author":"Kwon","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2025.118910_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0003319713513492","article-title":"Endocan-a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study","volume":"65","author":"Balta","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.biopha.2025.118910_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.566410","article-title":"Angiotensin II decreases endothelial nitric oxide synthase phosphorylation AT1R Nox\/ROS\/PP2A pathway","volume":"11","author":"Ding","year":"2020","journal-title":"Front Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118910_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yjmcc.2006.05.023","article-title":"Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation","volume":"42","author":"Mount","year":"2007","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118910_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10456-014-9455-0","article-title":"Tipping off endothelial tubes: nitric oxide drives tip cells","volume":"18","author":"Priya","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2025.118910_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156482","article-title":"Proinflammatory signaling mechanism of endocan in macrophages: Involvement of TLR2 mediated MAPK-NFkB pathways","volume":"175","author":"Kumar","year":"2024","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.biopha.2025.118910_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1074\/jbc.M309552200","article-title":"Tumor necrosis factor-\u03b1 inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells","volume":"279","author":"Anderson","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118910_bib38","doi-asserted-by":"crossref","first-page":"C1057","DOI":"10.1152\/ajpcell.2001.280.5.C1057","article-title":"TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells","volume":"280","author":"Kim","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:27:59Z","timestamp":1769034479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0753332225011047"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118910","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing endocan reduces blood pressure and improves endothelial function in angiotensin II-induced hypertensive mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118910"}}